These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1647395)

  • 1. Evidence that estramustine binds MAP-1A to inhibit type IV collagenase secretion.
    Stearns ME; Wang M; Sousa O
    J Cell Sci; 1991 Jan; 98 ( Pt 1)():55-63. PubMed ID: 1647395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estramustine binds MAP-2 to inhibit microtubule assembly in vitro.
    Stearns ME; Tew KD
    J Cell Sci; 1988 Mar; 89 ( Pt 3)():331-42. PubMed ID: 3198696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.
    Stearns ME; Wang M; Tew KD; Binder LI
    J Cell Biol; 1988 Dec; 107(6 Pt 2):2647-56. PubMed ID: 3060470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking of collagenase secretion by estramustine during in vitro tumor cell invasion.
    Wang M; Stearns ME
    Cancer Res; 1988 Nov; 48(22):6262-71. PubMed ID: 2846150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antineoplastic agent estramustine and the derivative estramustine-phosphate inhibit secretion of interleukin-3 in leukemic cells. Possible roles of MAPs.
    Martínez J; Santibáñez JF; Vial C; Maccioni RB
    Mol Cell Biochem; 1992 Nov; 117(2):165-73. PubMed ID: 1488050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of estramustine derivatives on microtubule assembly in vitro depends on the charge of the substituent.
    Fridén B; Rutberg M; Deinum J; Wallin M
    Biochem Pharmacol; 1991 Aug; 42(5):997-1006. PubMed ID: 1908244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and tau.
    Moraga D; Rivas-Berrios A; Farías G; Wallin M; Maccioni RB
    Biochim Biophys Acta; 1992 May; 1121(1-2):97-103. PubMed ID: 1599956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of estramustine phosphate with microtubule-associated proteins.
    Wallin M; Deinum J; Fridén B
    FEBS Lett; 1985 Jan; 179(2):289-93. PubMed ID: 2857133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estramustine phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP2, or the tubulin-binding fragment of MAP2.
    Fridén B; Wallin M; Deinum J; Prasad V; Luduena R
    Arch Biochem Biophys; 1987 Aug; 257(1):123-30. PubMed ID: 3115177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stoichiometry of estramustine phosphate binding to MAP2 measured by the disassembly of chick brain MAP2:tubulin microtubules.
    Burns RG
    Cell Motil Cytoskeleton; 1990; 17(3):167-73. PubMed ID: 2125244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen mustard induces cell cycle arrest of human epithelial ovarian cancer cell lines.
    Nathan JD; Keefe DL; Weinstein MA; Chen Z; Naftolin F
    J Soc Gynecol Investig; 1994; 1(1):97-103. PubMed ID: 9419755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
    Speicher LA; Laing N; Barone LR; Robbins JD; Seamon KB; Tew KD
    Mol Pharmacol; 1994 Nov; 46(5):866-72. PubMed ID: 7969073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The secretion of urokinase-like plasminogen activator is inhibited by microtubule-interacting drugs.
    Santibañez JF; Maccioni RB; Martínez J
    Cell Biochem Funct; 1995 Sep; 13(3):217-25. PubMed ID: 7554101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependency of microtubule-associated proteins (MAPs) for tubulin stability and assembly; use of estramustine phosphate in the study of microtubules.
    Fridén B; Wallin M
    Mol Cell Biochem; 1991 Jul; 105(2):149-58. PubMed ID: 1681420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins.
    Smith CD; Zilfou JT; Zhang X; Hudes GR; Tew KD
    Cancer; 1995 May; 75(10):2597-604. PubMed ID: 7736407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular effects of estramustine (Estracyt/Emcyt).
    Tew KD; Stearns ME
    Prog Clin Biol Res; 1989; 303():169-75. PubMed ID: 2674983
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunofluorescent studies of the anti-microtubule effects of the anti-cancer drug estramustine.
    Wang M; Tew KD; Stearns ME
    Anticancer Res; 1987; 7(6):1165-71. PubMed ID: 3327449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and metabolism of estramustine in the Dunning R3327H tumour.
    Kruse E; Hartley-Asp B
    In Vivo; 1988; 2(6):371-5. PubMed ID: 2979955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread cellular distribution of MAP-1A (microtubule-associated protein 1A) in the mitotic spindle and on interphase microtubules.
    Bloom GS; Luca FC; Vallee RB
    J Cell Biol; 1984 Jan; 98(1):331-40. PubMed ID: 6142895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estramustine depolymerizes microtubules by binding to tubulin.
    Dahllöf B; Billström A; Cabral F; Hartley-Asp B
    Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.